Skip to main content
    P

    Passage Bio Inc (PASG)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.22
    +0.09 (+2.18%)

    Market Cap: $13.29M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Passage Bio Inc (PASG) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Passage Bio (PASG) has a market cap of $13.29M. It holds $20.16M more cash than debt, 151.70% of its market cap.

    Total Valuation

    Market Cap$13.29M
    Latest price (Nov 17, 2026)$4.22

    Key Dates

    The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 1, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.28% in the quarter ended Sep 30, 2026 and grew 1.13% a year over 2 years.

    Shares Outstanding3.22M
    Shares Change (YoY)+1.23%
    Shares Change (QoQ)+0.28%
    Share Count Growth (2Y CAGR)+1.13%

    Price Statistics

    The stock is down 52.32% over 52 weeks and trades 3.18% above its 50-day average.

    Beta (1Y)1.96
    52-Week Change-52.32%
    1-Month Change+17.88%
    3-Month Change-6.43%
    6-Month Change-16.93%
    5-Year Change-98.02%
    Total Return (1Y)-52.32%
    Total Return (3Y CAGR)-29.41%
    Total Return (5Y CAGR)-51.93%
    Return vs SPY (1Y)-62.03%
    Max Drawdown (1Y)-83.27%
    Max Drawdown (3Y)-90.40%
    Sharpe Ratio (1Y)-0.60
    Correlation with SPY (1Y)0.23
    50-Day Average$4.09
    200-Day Average$5.74
    52-Week Range$3.29 to $20.00
    RSI (14 Days)58.5
    Average Volume (20 Days)16.44K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.00x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.00x
    Quick Ratio1.00x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -66164.00% and return on assets is -159.10% over the last 12 months.

    Return on Equity (ROE)-66164.00%
    Return on Assets (ROA)-159.10%
    Return on Capital Employed (ROCE)-66164.00%
    ROA (5Y Average)-62.45%

    Scores

    PASG has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Gross Profit-$177.00K
    Operating Income-$35.31M
    Pretax Income-$33.08M
    Net Income-$33.08M
    EBITDA-$32.75M
    EBIT-$33.08M
    Reported EPS (TTM)-$10.36

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 0.24% of the $20.79M in total assets.

    Cash and Equivalents$20.16M
    Total Debt$0
    Net Cash$20.16M
    Net Cash Per Share$6.27
    Working Capital$50.00K
    Shareholder Equity$50.00K
    Book Value Per Share$0.02
    Total Assets$20.79M
    Total Liabilities$20.74M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$32.65M
    FCF Per Share-$10.15

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-61.80%
    Tangible Book Per Share Growth (2Y CAGR)-61.80%

    Revenue and profit by year

    Dividends and Yields

    PASG does not pay a dividend.

    Buyback Yield-0.07%
    Shareholder Yield-0.07%

    Stock Splits

    The last split was a 1-for-20 reverse split on Jul 14, 2025.

    Last Split DateJul 14, 2025
    Split TypeReverse split
    Split Ratio1:20

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About PASG

    What is PASG's market cap?

    Passage Bio has a market cap of $13.29M.

    How many shares of PASG are outstanding?

    Passage Bio has 3.22M shares outstanding. The count is up 1.23% from a year earlier.

    Does PASG pay a dividend?

    No. Passage Bio does not pay a dividend.

    How much debt does PASG have?

    Passage Bio has $0 of total debt and $20.16M of cash and equivalents, a net cash position of $20.16M.